Key Record Dates Identifier: NCT03639987
Brief Title: A Study of Aducanumab in Participants With Mild Cognitive Impairment Due to Alzheimer's Disease or With Mild Alzheimer's Disease Dementia to Evaluate the Safety of Continued Dosing in Participants With Asymptomatic Amyloid-Related Imaging Abnormalities

First Submitted : August 17, 2018
First Submitted that Met QC Criteria : August 17, 2018
First Posted : August 21, 2018

Last Update Submitted that Met QC Criteria : March 19, 2019
Last Update Posted : March 20, 2019 (Estimate)